Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines

Cornel J. Phillip(The University of Texas Health Science Center at Houston), Varsha Gandhi(The University of Texas Health Science Center at Houston)
Journal of Hematology & Oncology
December 1, 2013
Cited by 22


Related Papers